Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 425 for “"SAHA"”.

  1. Synthesis of novel heterocyclic compounds that enhance the anticancer effects of Saha

    … lower concentration, considerably enhanced the SAHA toxicity. Encouragingly, the toxicity of designated systems on the normal human cells was found to be significantly less than the cancer cells. The nucleophilic substitution of methyl hydroxyindole esters with α-haloketones yielded the …

    unsw Repository record for Synthesis of novel heterocyclic compounds that enhance the anticancer effects of Saha (opens in a new tab)

  2. Therapeutic potential of the anti-fibrotic drug Suberanilohydroxamic acid (SAHA) in canine corneal fibrosis

    … mechanisms mediating the antifibrotic effect of SAHA in the canine cornea using an in vitro model and (2) to develop a novel in vivo model of corneal fibrosis in dogs utilizing alkali burn and assess the ability of SAHA to inhibit fibrosis using this canine model. Methods: In study 1, canine …

    missouri Repository record for Therapeutic potential of the anti-fibrotic drug Suberanilohydroxamic acid (SAHA) in canine corneal fibrosis (opens in a new tab)

  3. The effects of SAHA and EGCG on metastatic potential in triple-negative breast cancer cells

    … potential. Suberoylanilide hydroxamic acid (SAHA) is an FDA-approved chemotherapeutic agent and epigallocatechin-3-gallate (EGCG) is a green tea polyphenol. We investigated the mechanisms behind the increase in breast cancer cell death with SAHA and EGCG through the lens of metastatic …

    uab Repository record for The effects of SAHA and EGCG on metastatic potential in triple-negative breast cancer cells (opens in a new tab)

  4. Design, Synthesis And Biological Evaluation Of Histone Deacetylase (hdac) Inhibitors: Saha (vorinostat) Analogs And Biaryl Indolyl Benzamide Inhibitors Display Isoform Selectivity

    … by the FDA as anti-cancer drugs, including SAHA (suberoylanilide hydroxamic acid, Vorinostat). Unfortunately, SAHA inhibits most HDAC isoforms, which limit its use as a pharmacological tool and may lead to side effects in the clinic. In this work we were interested in developing isoform …

    wayne-thes Repository record for Design, Synthesis And Biological Evaluation Of Histone Deacetylase (hdac) Inhibitors: Saha (vorinostat) Analogs And Biaryl Indolyl Benzamide Inhibitors Display Isoform Selectivity (opens in a new tab)

  5. The structural requirements of histone deacetylase (hdac) inhibitors: suberoylanilide hydroxamic acid (saha) analogues modified at c3, c6, and c7 positions enhance selectivity

    … approved drug suberoylanilide hydroxamic acid (SAHA, Vorinostat), have cleared clinical trials and emerged as anti-cancer drugs. However, SAHA inhibits all of the 11 metal ion-dependent HDAC proteins. Therefore, we synthesized several libraries of small molecule HDAC inhibitors based on SAHA to …

    wayne-thes Repository record for The structural requirements of histone deacetylase (hdac) inhibitors: suberoylanilide hydroxamic acid (saha) analogues modified at c3, c6, and c7 positions enhance selectivity (opens in a new tab)

  6. The effect of SAHA on the expression of genes in wild type and Hdac2 knockout mouse models and its potential use as treatment for schizophrenia

    … given in conjunction with the HDAC inhibitor, SAHA, the cognitive memory deficits of mouse models decline. HDAC2KO mice were bred and used in chronic treatments with either vehicle or SAHA and compared to WT mice, in order to analyze whether differential gene expression was occurring in an …

    vcu Repository record for The effect of SAHA on the expression of genes in wild type and Hdac2 knockout mouse models and its potential use as treatment for schizophrenia (opens in a new tab)

  7. Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen

    Die neu entwickelten Substanzen 3BrQuin-SAHA, 3ClQuin-SAHA, zwei chimäre EGFR/HDAC-Inhibitoren, und SF5-SAHA, ein HDAC-Inhibitor, wurden in ihrer Wirkung und Wirkmechanismen an Zellen des Prostata- (PCa) und hepatozellulären (HCC) Karzinoms genauer charakterisiert. Eine Verbesserung der Therapie …

    fu-berlin Repository record for Untersuchungen zur antineoplastischen Wirkung neuartiger HDAC-Inhibitoren bei Prostata- und hepatozellulären Karzinomen (opens in a new tab)

  8. Histone deacetylase inhibition-mediated cytotoxicity of oligodendrocytes.

    … inhibitor suberoylanilide hydroxamic acid (SAHA), approximately 65% reduction in cell survival relative to vehicle-treated OPCs was observed. SAHA-mediated death of OPCs induces apoptosis partly by caspase activation with improvement of OPC survival when SAHA is accompanied by treatment with …

    louisville Repository record for Histone deacetylase inhibition-mediated cytotoxicity of oligodendrocytes. (opens in a new tab)

  9. Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors

    … are in various stages of clinical trials. SAHA and Romidepsin are FDA-approved drugs for the treatment of cutaneous T-cell lymphoma. Human HDAC proteins have high sequence similarity and hence many known inhibitors non-specifically interact with all or most of the eleven HDAC isoforms, …

    wayne-thes Repository record for Development Of Elisa-Based Hdac Activity Assay For Identification Of Isoform Selective Hdac Inhibitors (opens in a new tab)

  10. Defining The Role of Egfr Acetylation In Cellular Processes: Clinical Implications

    … observed that suberoylanilide hydroxamic acid (SAHA, a deacetylase inhibitor) enhanced TKI-induced cancer cell death, which further led us to question whether SAHA-mediated sensitization to TKI was associated with EGFR acetylation. What we know so far is that SAHA can inhibit class I and II …

    uthsc Repository record for Defining The Role of Egfr Acetylation In Cellular Processes: Clinical Implications (opens in a new tab)

  11. Histone Deacetylase Inhibitors and Innate Immunity in Septic Shock

    … A (TSA) and Suberoylanilide hydroxamic acid (SAHA) (both broad spectrum HDAC inhibitors) and ST-2-92 (HDAC6 specific inhibitor) on IFN regulation and endotoxic shock. We created an in vivo mouse model for this treatment with TSA and SAHA (which are well tolerated in mouse and human) to look …

    vcu Repository record for Histone Deacetylase Inhibitors and Innate Immunity in Septic Shock (opens in a new tab)

  12. Investigating Phenotypic Changes in Response to Drug Treatments in Epithelial Ovarian Cancer Using a Novel Si-TiB2 Micropatterned Substrate

    … also known as suberoylanilide hydroxamic acid (SAHA), resulted in decreased diameter and thickness, however viability of the remaining cells was unchanged. Genomic analysis of the treated aggregates suggests a change in phenotype of SKOV3 after treatment with SAHA. While studies show that SAHA …

    houston Repository record for Investigating Phenotypic Changes in Response to Drug Treatments in Epithelial Ovarian Cancer Using a Novel Si-TiB2 Micropatterned Substrate (opens in a new tab)

  13. Erzeugung von Histondeazetylase-Hemmer-resistenten Tumorzellen durch mehrfache Behandlung mit ansteigenden Konzentrationen von Trichostatin A

    … FK228 wie auch das Hydroxamsäurederivat SAHA eine Resistenz bei Tumorzellen verursachen kann, was darauf hindeutet, dass möglicherweise Histondeazetylasen-Hemmer neben ihrer nachweislich chemotherapeutischen Wirkung auch das Potenzial haben, Resistenzen zu verursachen. Die hier …

    zurich

  14. Investigating the role of MHC class I molecules in immune evasion by transmissible tumour cells

    … MHC class I molecules, and non-classical, Saha-UD and Saha-UK. An expression score was generated using semi-automated image analysis to quantify IHC staining. To investigate host immune responses to MHC class I expression, tumours were also stained for IFNγ (DFT1, n=51; DFT2, n=25) and CD3 …

    soton Download PDF for Investigating the role of MHC class I molecules in immune evasion by transmissible tumour cells (opens in a new tab)

  15. Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson’s disease

    … of the HDAC-Is, suberoylanilide hydroxamic acid (SAHA) and valproic acid (VPA) were investigated in in vitro and in vivo models of PD. Neither inhibitors protected dopaminergic cell lines, SH-SY5Y and N1E-115, against hydrogen-peroxide (H2O2) and MPP+-induced toxicity. Except, at the highest …

    kings Repository record for Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson’s disease (opens in a new tab) Download PDF for Histone deacetylase inhibitors as novel neuroprotective agents in in vitro and in vivo models of Parkinson’s disease (opens in a new tab)

  16. O papel da autofagia na resistência de gliomas ao tratamento com temozolomida e inibidor de histonas desacetilases

    … limitado. O ácido hidroxâmico suberoilanilida (SAHA) é um inibidor específico de histonas desacetilases aprovado para o tratamento de linfoma cutâneo de células T, e em fase de crescente investigação clínica e pré-clínica em tumores sólidos. Neste estudo, avaliamos a eficácia do ácido …

    brazil-ufrgs Repository record for O papel da autofagia na resistência de gliomas ao tratamento com temozolomida e inibidor de histonas desacetilases (opens in a new tab)

  17. Untersuchungen in vitro zu epigenetisch wirksamen Immunmodulatoren bei der Pathogen-spezifischen Mastitis des Rindes

    … three selected epigenetic modifiers (ViD3, SAHA and S2101) influence the initial immune response towards mastitis pathogens in bovine udder tissue in vitro. Additionally, the epigenetic signature of polymorphonuclear neutrophils (PMN) should be identified for the better understanding of …

    lmu-germany Repository record for Untersuchungen in vitro zu epigenetisch wirksamen Immunmodulatoren bei der Pathogen-spezifischen Mastitis des Rindes (opens in a new tab)

  18. Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition

    … HDIs in L1210 cells. Interestingly, MS-275 or SAHA in combination with the viral mimic imiquimod additively reduced L1210 cell viability. Hence, we hypothesize that OVs may sensitize B-ALL cells to HDI-mediated toxicity. In vivo, MG1 in combination with SAHA and MS-275 appeared to enhance …

    guelph Repository record for Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition (opens in a new tab)

  19. Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese eines Phänotyps in der Milz im myeloproliferativen Mausmodell in vivo

    … NF-E2 transgene Mäuse mit dem HDAC-Inhibitor SAHA (suberoylanilide hydroxamic acid) behandelt, der im Modell zur Verbesserung der hämatologischen Parameter führt, so entwickeln sie eine extensive Steigerung der extramedullären Hämatopoiese in der Milz, die begleitet ist von einer stärkeren …

    freiburg-diss Repository record for Der Transkriptionsfaktor NF-E2 und seine Rolle in der Pathogenese eines Phänotyps in der Milz im myeloproliferativen Mausmodell in vivo (opens in a new tab)

  20. Novas modalidades terapêuticas para o carcinoma mucoepidermoide e seus efeitos na população de células tronco tumorais

    … e acetilação de histonas (tratamento com SAHA). Os resultados mostraram que uma dose de Emetine é capaz de inibir a proliferação celular em todas as linhagens de CME analisadas, enquanto que o SAHA apresentou este efeito em apenas 50% das linhagens. Por outro lado, o SAHA foi mais eficaz …

    brazil-ufrgs Repository record for Novas modalidades terapêuticas para o carcinoma mucoepidermoide e seus efeitos na população de células tronco tumorais (opens in a new tab)

Page 1 of 22